BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16055357)

  • 1. Isolation of TPO-dependent subclones from the multipotent 32D cell line.
    Amabile G; Di Noia A; Alfani E; Vannucchi AM; Sanchez M; Bosco D; Migliaccio AR; Migliaccio G
    Blood Cells Mol Dis; 2005; 35(2):241-52. PubMed ID: 16055357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin (TPO) induces c-myc expression through a PI3K- and MAPK-dependent pathway that is not mediated by Akt, PKCzeta or mTOR in TPO-dependent cell lines and primary megakaryocytes.
    Chanprasert S; Geddis AE; Barroga C; Fox NE; Kaushansky K
    Cell Signal; 2006 Aug; 18(8):1212-8. PubMed ID: 16380230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate effects of interleukin 11 and thrombopoietin on megakaryocytopoiesis in vitro.
    Taguchi K; Saitoh M; Arai Y; Momose K; Ogawa Y; Yasuda S; Miyata K
    Cytokine; 2001 Sep; 15(5):241-9. PubMed ID: 11594788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin is required for thrombopoietin-induced proliferation of megakaryocyte progenitors.
    Drayer AL; Olthof SG; Vellenga E
    Stem Cells; 2006 Jan; 24(1):105-14. PubMed ID: 16123382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
    Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
    Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon-alpha directly inhibits thrombopoietin-induced megakaryocyte proliferation and differentiation].
    Wang Q; Fox NE; Kaushansky K
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jun; 22(6):296-9. PubMed ID: 11877087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel thrombopoietin-stem-cell factor fusion protein possesses enhanced potential in stimulating megakaryocyte proliferation and differentiation.
    Zang Y; Zhang Y; Peng W; Chen B; Zhu J; Zhang C; Ouyang J; Qin J
    Biotechnol Appl Biochem; 2007 Nov; 48(Pt 3):135-42. PubMed ID: 17516919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation.
    Carta C; Campisi S; Migliaccio G; Migliaccio AR
    Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megakaryocytopoietic activity of a truncated variant of mouse thrombopoietin.
    Hoshi S; Yoshitomi H; Komatsu N; Yoshitake S; Okada M
    Biochem Biophys Res Commun; 1997 Feb; 231(3):823-6. PubMed ID: 9070902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and inhibitory interactions in the in vitro control of murine megakaryocyte colony formation.
    Metcalf D; Di Rago L; Mifsud S
    Stem Cells; 2002; 20(6):552-60. PubMed ID: 12456963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of micro RNA in proliferating and differentiating 32D murine myeloid cells.
    Shi B; Prisco M; Calin G; Liu CG; Russo G; Giordano A; Baserga R
    J Cell Physiol; 2006 Jun; 207(3):706-10. PubMed ID: 16482530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11.
    Feng Y; Zhang L; Xiao ZJ; Li B; Liu B; Fan CG; Yuan XF; Han ZC
    Exp Hematol; 2005 Dec; 33(12):1537-43. PubMed ID: 16338497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
    Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
    Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of chicken thrombopoietin and its receptor c-Mpl on hematopoietic cell development.
    Bartunek P; Karafiat V; Bartunkova J; Pajer P; Dvorakova M; Kralova J; Zenke M; Dvorak M
    Exp Hematol; 2008 Apr; 36(4):495-505. PubMed ID: 18243490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the GPI-anchored receptor Prv-1 enhances thrombopoietin and IL-3-induced proliferation in hematopoietic cell lines.
    Dillon M; Minear J; Johnson J; Lannutti BJ
    Leuk Res; 2008 May; 32(5):811-9. PubMed ID: 17980909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocyte development and platelet production.
    Deutsch VR; Tomer A
    Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.